PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma

Clinical trial NCT00073892 · COMPLETED

Trial details

NCT number: NCT00073892
Sponsor: Cellxpert Biotechnology Corp.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2004-01-01
Primary completion: 2005-11-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.